iLite® ADCC Target mVEGF (-) Assay Ready Cells can be used for assessing the possibility of an anti-VEGF antibody drug inducing ADCC.
iLite® mVEGF (-) Target Assay Ready Cells are based on a human embryonic kidney cell line, HEK2931, and have been genetically engineered to not express any membrane bound VEGF.
The cells are for use as internal controls together with iLite® ADCC Effector (V) Assay Ready Cells and iLite® mVEGF (+) Target Assay Ready Cells for measuring the ADCC activity of anti-VEGF antibodies.
* The HEK-293 cell line has been used under a license obtained from AdVec Inc.
FOR RESEARCH USE ONLY
Product code | BM5018 |
Assay target | mVEGF |
Size | 1 vial corresponding to one 96 well plate |
Technology | Cell-based reporter gene assay |
Read-out of results | Quantitative, |
Detection system | Luminescence |
Regulatory status | Research Use Only |
>250 μL of Assay Ready Cells suspended in cryoprotective medium from Gibco (cat no 12648-010)
> Read more > Read lessGet access to scientific material, posters and more.